Depression and anxiety as risk factors for morbidity and mortality after organ transplantation: A systematic review and meta-analysis

Transplantation

Volumn 100, Issue 5, 2016, Pages 988-1003

  Amanda Dew, Mary ^a,b   Rosenberger, Emily M ^a   Myaskovsky, Larissa ^a,c   DiMartini, Andrea F ^a,d   DeVito Dabbs, Annette J ^e   Posluszny, Donna M ^a   Steel, Jennifer ^d   Switzer, Galen E ^a,c   Shellmer, Diana A ^d   Greenhouse, Joel B ^f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT REJECTION; ANXIETY; ANXIETY DISORDER; CHRONIC GRAFT REJECTION; DEPRESSION; GRAFT FAILURE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HOSPITAL READMISSION; HUMAN; INFECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MORBIDITY; MORTALITY; NEOPLASM; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADVERSE EFFECTS; COMMUNICABLE DISEASE; FEMALE; GRAFT REJECTION; MALE; META ANALYSIS; ODDS RATIO; PSYCHOLOGY; RISK ASSESSMENT; TIME FACTOR;

ANXIETY; COMMUNICABLE DISEASES; DEPRESSION; FEMALE; GRAFT REJECTION; HUMANS; MALE; NEOPLASMS; ODDS RATIO; ORGAN TRANSPLANTATION; PATIENT READMISSION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84944754831     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000901     Document Type: Review

References (121)

1. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients (OPTN/SRTR) (2014). 2013 Annual Data Report. Rockville, MD: Dept. of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation.
2. Dew MA, Dimartini AF. Organ transplantation. In: Friedman HS, editor. Oxford Handbook of Health Psychology. New York: Oxford University Press; 2011:522-559.
3. Annunziato RA, Jerson B, Seidel J, et al. The psychosocial challenges of solid organ transplant recipients during childhood. Pediatr Transplant. 2012;16:803-811.
4. Corbett C, Armstrong MJ, Parker R, et al. Mental health disorders and solid-organ transplant recipients. Transplantation. 2013;96:593-600.
5. Psychosocial OutcomesWorkgroup of the Nursing and Social Sciences Council of the International Society for Heart and Lung Transplantation, Cupples S, Dew MA, Grady KL, et al. Report of the Psychosocial OutcomesWorkgroup of the Nursing and Social Sciences Council of the International Society for Heart and Lung Transplantation: present status of research on psychosocial outcomes in cardiothoracic transplantation: review and recommendations for the field. J Heart Lung Transplant. 2006;25:716-725.
6. Dimartini A, Dew MA, Crone C. Organ transplantation. In: Sadock BJ, Sadock VA, Ruiz P, eds. Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 9th ed. Vol. 2. Philadelphia: Lippincott Williams & Wilkins; 2009:2441-2456.
7. Atlantis E, Fahey P, Cochrane B, et al. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013;144:766-777.
8. Cuijpers P, Vogelzangs N, Twisk J, et al. Is excess mortality higher in depressedmen than in depressed women? A meta-analytic comparison. J Affect Disord. 2014;161:47-54.
9. EatonWW, Martins SS, Nestadt G, et al. The burden ofmental disorders. Epidemiol Rev. 2008;30:1-14.
10. Fan H, YuW, Zhang Q, et al. Depression after heart failure and risk of cardiovascular and all-causemortality: a meta-analysis. Prev Med. 2014;63: 36-42.
11. Gross AL, Gallo JJ, Eaton WW. Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample. Cancer Causes Control. 2010;21:191-199.
12. Kessler RC. The costs of depression. Psychiatr Clin North Am. 2012;35: 1-14.
13. Kubzansky LD, Koenen KC, Jones C, et al. A prospective study of posttraumatic stress disorder symptoms and coronary heart disease in women. Health Psychol. 2009;28:125-130.
14. Oerlemans ME, van den Akker M, Schuurman AG, et al. A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemiol Ment Health. 2007;3:29.
15. Pan A, Lucas M, Sun Q, et al. Increased mortality risk in women with depression and diabetes mellitus. Arch Gen Psychiatry. 2011;68: 42-50.
16. Pooler A, Beech R. Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J Chron Obstruct Pulmon Dis. 2014;9:315-330.
17. Watkins LL, Koch GG, Sherwood A, et al. Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. J AmHeart Assoc. 2013;2:e000068.
18. Wrenn KC, Mostofsky E, Tofler GH, et al. Anxiety, anger, and mortality risk among survivors of myocardial infarction. Am JMed. 2013;126:1107-1113.
19. Olbrisch ME, Benedict SM, Ashe K, et al. Psychological assessment and care of organ transplant patients. JConsultClinPsychol. 2002;70:771-783.
20. Steinman TI, Becker BN, Frost AE, et al. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation. 2001;71:1189-1204.
21. Maldonado JR, Dubois HC, David EE, et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics. 2012;53:123-132.
22. Dew MA, Dimartini AF. Psychological disorders and distress after adult cardiothoracic transplantation. J Cardiovasc Nurs. 2005;20(5 Suppl): S51-S66.
23. Fusar-Poli P, Lazzaretti M, Ceruti M, et al. Depression after lung transplantation: causes and treatment. Lung. 2007;185:55-65.
24. Zalai D, Szeifert L, NovakM. Psychological distress and depression in patients with chronic kidney disease. Semin Dial. 2012;25:428-438.
25. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54:216-226.
26. Polsky D, Doshi JA,Marcus S, et al. Long-termrisk for depressive symptoms after a medical diagnosis. Arch Intern Med. 2005;165:1260-1266.
27. Dew MA. Psychiatric disorder in the context of physical illness. In: Dohrenwend BP, ed. Adversity, Stress and Psychopathology. NewYork: Oxford University Press; 1998:177-218.
28. Hedayati SS, Finkelstein FO. Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis. 2009;54:741-752.
29. Mitchell AJ, Ferguson DW, Gill J, et al. Depression and anxiety in longterm cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013;14: 721-732.
30. Whooley MA,Wong JM. Depression and cardiovascular disorders. Annu Rev Clin Psychol. 2013;9:327-354.
31. Dimartini A, Dew MA, Chaiffetz D, et al. Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival. Am J Transplant. 2011;11:1287-1295.
32. Dobbels F, Skeans MA, Snyder JJ, et al. Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis. 2008;51:819-828.
33. Havik OE, Sivertsen B, Relbo A, et al. Depressive symptoms and allcause mortality after heart transplantation. Transplantation. 2007;84: 97-103.
34. NovakM, Molnar MZ, Szeifert L, et al. Depressive symptoms andmortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med. 2010;72:527-534.
35. Smith PJ, Blumenthal JA, Carney RM, et al. Neurobehavioral functioning and survival following lung transplantation. Chest. 2014; 145:604-611.
36. Rogal SS, Landsittel D, Surman O, et al. Pretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation. Liver Transpl. 2011;17:251-260.
37. Rowley AA, Hong BA, ChapmanW, et al. The psychiatric diagnosis of alcohol abuse and the medical diagnosis of alcoholic related liver disease: effects on liver transplant survival. J Clin Psychol Med Settings. 2010;17: 195-202.
38. Skotzko CE, Rudis R, Kobashigawa JA, et al. Psychiatric disorders and outcome following cardiac transplantation. J Heart Lung Transplant. 1999;18:952-956.
39. Corruble E, Barry C, Varescon I, et al. Report of depressive symptoms on waiting list and mortality after liver and kidney transplantation: a prospective cohort study. BMC Psychiatry. 2011;11:182.
40. Burke A. Could anxiety, hopelessness and health locus of control contribute to the outcome of a kidney transplant? South African J Psychol. 2006;38:527-540.
41. Rosenberger EM, Dew MA, Crone C, et al. Psychiatric disorders as risk factors for adverse medical outcomes after solid organ transplantation. Curr Opin Organ Transplant. 2012;17:188-192.
42. Dobbels F, Verleden G, Dupont L, et al. To transplant or not? The importance of psychosocial and behavioural factors before lung transplantation. Chron Respir Dis. 2006;3:39-47.
43. Huang E, Segev DL, Rabb H. Kidney transplantation in the elderly. Semin Nephrol. 2009;29:621-635.
44. Mullish BH, Kabir MS, Thursz MR, et al. Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation. Aliment Pharmacol Ther. 2014;40:880-892.
45. Rook M, Rand E. Predictors of long-term outcome after liver transplant. Curr Opin Organ Transplant. 2011;16:499-504.
46. Rosenberger EM, Fox KR, Dimartini AF, et al. Psychosocial factors and quality-of-life after heart transplantation and mechanical circulatory support. Curr Opin Organ Transplant. 2012;17:558-563.
47. Moher D, Liberati A, Tetzlaff J; PRISMA Group, et al. Preferred reporting items for systematic reviews andmeta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006-1012.
48. Floege J, Johnson RJ, Feehally J. Comprehensive Clinical Nephrology. 4th ed. New York: Elsevier; 2011.
49. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-2834.
50. Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S. editors, Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0. The Cochrane Collaboration, 2011. Available at: www. cochrane-handbook. org. Accessed April 12th, 2016.
51. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283: 2008-2012.
52. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and nonrandomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377-384.
53. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:e297.
54. Borenstein M, Hedges LV, Higgins JP, et al. Introduction to Meta-Analysis. New York: Wiley; 2009.
55. Rosenthal R. The file-drawer problem and tolerance for null results. Psychol Bull. 1979;86:638-641.
56. Greenhouse JB, Iyengar S. Sensitivity analysis and diagnostics. In: Cooper H, Hedges LV, Valentine JC, editors. The Handbook of Research Synthesis and Meta-Analysis. 2nd ed. NY: Russell Sage Foundation; 2009:417-433.
57. Bailar JC 3rd. The promise and problems of meta-analysis. N Engl J Med. 1997;337:559-561.
58. Maricle RA, Hosenpud JD, Norman DJ, et al. Depression in patients being evaluated for heart transplantation. Gen Hosp Psychiatry. 1989;11: 418-424.
59. Maricle RA, Hosenpud JD, Norman DJ, et al. The lack of predictive value of preoperative psychologic distress for postoperativemedical outcome in heart transplant recipients. J Heart Lung Transplant. 1991;10:942-947.
60. DewMA, Kormos RL, Roth LH, et al. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999; 18:549-562.
61. Zipfel S, Schneider A, Wild B, et al. Effect of depressive symptoms on survival after heart transplantation. PsychosomMed. 2002;64:740-747.
62. Grigioni F, Musuraca AC, Tossani E, et al. Relationship between psychiatric disorders and physical status during the course of a heart transplantation program: a prospective, longitudinal study. Ital Heart J. 2005;6: 900-903.
63. Sirri L, Potena L, Masetti M, et al. Psychological predictors of mortality in heart transplanted patients: a prospective, 6-year follow-up study. Transplantation. 2010;89:879-886.
64. Owen JE, Bonds CL,Wellisch DK. Psychiatric evaluations of heart transplant candidates: predicting post-transplant hospitalizations, rejection episodes, and survival. Psychosomatics. 2006;47:213-222.
65. van de Beek D, Kremers W, Daly RC, et al. Effect of neurologic complications on outcome after heart transplant. Arch Neurol. 2008;65: 226-231.
66. Favaro A, Gerosa G, Caforio AL, et al. Posttraumatic stress disorder and depression in heart transplantation recipients: the relationship with outcome and adherence to medical treatment. Gen Hosp Psychiatry. 2011;33:1-7.
67. Farmer SA, Grady KL, Wang E, et al. Demographic, psychosocial, and behavioral factors associated with survival after heart transplantation. Ann Thorac Surg. 2013;95:876-883.
68. Singh N, Gayowski T,WagenerMM, et al. Depression in patients with cirrhosis. Impact on outcome. Dig Dis Sci. 1997;42:1421-1427.
69. Gedaly R, McHugh PP, Johnston TD, et al. Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease. Transplantation. 2008;86:1090-1095.
70. Corruble E, Barry C, Varescon I, et al. Depressive symptoms predict longterm mortality after liver transplantation. J Psychosom Res. 2011;71:32-37.
71. Corruble E, Barry C, Varescon I, et al. The Transplanted Organ Questionnaire: a validation study. J PsychosomRes. 2012;73:319-324.
72. Rogal SS, Dew MA, Fontes P, et al. Early treatment of depressive symptoms and long-term survival after liver transplantation. Am J Transplant. 2013;13:928-935.
73. Molnar-Varga M, Molnar MZ, Szeifert L, et al. Health-related quality of life and clinical outcomes in kidney transplant recipients. Am J Kidney Dis. 2011;58:444-452.
74. Zelle DM, Dorland HF, Rosmalen JG, et al. Impact of depression on longterm outcome after renal transplantation: a prospective cohort study. Transplantation. 2012;94:1033-1040.
75. Cohen L, Littlefield C, Kelly P, et al. Predictors of quality of life and adjustment after lung transplantation. Chest. 1998;113:633-644.
76. Vermeulen KM, TenVergert EM, Verschuuren EA, et al. Pre-transplant quality of life does not predict survival after lung transplantation. J Heart Lung Transplant. 2008;27:623-627.
77. Evon DM, Burker EJ, Galanko JA, et al. Depressive symptoms and mortality in lung transplant. Clin Transplant. 2010;24:E201-E206.
78. PopkinMK, Callies AL, Colón EA, et al. Psychiatric diagnosis and the surgical outcome of pancreas transplantation in patients with type I diabetes mellitus. Psychosomatics. 1993;34:251-258.
79. Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87:1497-1504.
80. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0. The Cochrane Collaboration, 2011. Available at: www. cochrane-handbook. org. Accessed April 12th, 2016.
81. Rutledge T, Reis VA, Linke SE, et al. Depression in heart failure a metaanalytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527-1537.
82. Meijer A, Conradi HJ, Bos EH, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry. 2011; 33:203-216.
83. Meijer A, Conradi HJ, Bos EH, et al. Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis. Br J Psychiatry. 2013;203:90-102.
84. Palmer SC, Vecchio M, Craig JC, et al. Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis. 2013;62:493-505.
85. Pinquart M, Duberstein PR. Depression and cancer mortality: a metaanalysis. Psychol Med. 2010;40:1797-1810.
86. Kimbro LB, Mangione CM, Steers WN, et al. Depression and all-cause mortality in persons with diabetes mellitus: are older adults at higher risk? Results from the Translating Research Into Action for Diabetes study. J Am Geriatr Soc. 2014;62:1017-1022.
87. Oliva M, Singh TP, Gauvreau K, et al. Impact of medication nonadherence on survival after pediatric heart transplantation in the U. S. A. J Heart Lung Transplant. 2013;32:881-888.
88. Dew MA, Dabbs AD, Myaskovsky L, et al. Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation. 2009;88:736-746.
89. Li M, Rodin G. Depression. In: Levenson JL, editor. The American Psychiatric Publishing Textbook of Psychosomatic Medicine : Psychiatric Care of the Medically Ill. 2nd ed. Washington, DC: American Psychiatric Publishing, Inc. ; 2010:175-197.
90. Rush AJ, Nierenberg AA. Mood disorders: treatment of depression. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan and Sadock's Comprehensive Textbook of Psychiatry 9th ed, Vol. 2. Philadelphia: Lippincott Williams & Wilkins; 2009:1734-1743.
91. Harris J, Heil JS. Managing depression in patients with advanced heart failure awaiting transplantation. Am J Health Syst Pharm. 2013; 70:867-873.
92. Nagler EV, Webster AC, Vanholder R, et al. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2012;27: 3736-3745.
93. Crone CC, Gabriel GM. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations. Clin Pharmacokinet. 2004;43:361-394.
94. Dimartini A, Crone C, Fireman M, et al. Psychiatric aspects of organ transplantation in critical care. Crit Care Clin. 2008;24:949-981.
95. Fusar-Poli P, Picchioni M, Martinelli V, et al. Anti-depressive therapies after heart transplantation. J Heart Lung Transplant. 2006;25:785-793.
96. Heinrich TW, Marcangelo M. Psychiatric issues in solid organ transplantation. Harv Rev Psychiatry. 2009;17:398-406.
97. Beck AT, Steer RA, Brown CK. Beck Depression Inventory-Second Edition Manual. San Antonio, TX: Psychological Corp, Harcourt Brace Jovanovich; 1986.
98. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613.
99. Griva K, Davenport A, Harrison M, et al. Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medications intake. Ann Behav Med. 2012;44: 85-93.
100. De Geest S, Dobbels F, Fluri C, et al. Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients. J Cardiovasc Nurs. 2005;20(5 Suppl):S88-S98.
101. Rodrigue JR, Nelson DR, Hanto DW, et al. Patient-reported immunosuppression nonadherence 6 to 24months after liver transplant: association with pretransplant psychosocial factors and perceptions of health status change. Prog Transplant. 2013;23:319-328.
102. Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant. 2009;9:35-41.
103. Denhaerynck K, Dobbels F, Cleemput I, et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl Int. 2005;18:1121-1133.
104. Pagoto SL, Ma Y, Bodenlos JS, et al. Association of depressive symptoms and lifestyle behaviors among Latinos at risk of type 2 diabetes. J Am Diet Assoc. 2009;109:1246-1250.
105. GrannerML, Mburia-Mwalili A. Correlates of television viewing among African American and Caucasian women. Women Health. 2010;50:783-794.
106. Duivis HE, de Jonge P, Penninx BW, et al. Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry. 2011;168:913-920.
107. Strine TW, Mokdad AH, Dube SR, et al. The association of depression and anxiety with obesity and unhealthy behaviors among communitydwelling US adults. Gen Hosp Psychiatry. 2008;30:127-137.
108. Pantell M, Rehkopf D, Jutte D, et al. Social isolation: a predictor of mortality comparable to traditional clinical risk factors. Am J Public Health. 2013;103:2056-2062.
109. Barger SD. Social integration, social support and mortality in the US National Health Interview Survey. Psychosom Med. 2013;75:510-517.
110. Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Med. 2010;7:e1000316.
111. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, et al. C-Reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant metaanalysis. Lancet. 2010;375:132-140.
112. Hung KC, Wu CC, Chen HS, et al. Serum IL-6, albumin and comorbidities are closely correlated with symptoms of depression in patients on maintenance haemodialysis. Nephrol Dial Transplant. 2011;26:658-664.
113. Vaccarino V, Johnson BD, Sheps DS, et al. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsoredWISE Study. J AmColl Cardiol. 2007;50:2044-2050.
114. Cashion AK, Holmes SL, Arheart KL, et al. Heart rate variability and mortality in patients with end stage renal disease. Nephrol Nurs J. 2005;32:173-184.
115. Kojima M, Hayano J, Fukuta H, et al. Loss of fractal heart rate dynamics in depressive hemodialysis patients. Psychosom Med. 2008;70:177-185.
116. Berney-Martinet S, Key F, Bell L, et al. Psychological profile of adolescents with a kidney transplant. Pediatr Transplant. 2009;13:701-710.
117. Dew MA, Dimartini AF, DeVito Dabbs AJ, et al. Onset and risk factors for anxiety and depression during the first 2 years after lung transplantation. Gen Hosp Psychiatry. 2012;34:127-138.
118. Dew MA, Kormos RL, Dimartini AF, et al. Prevalence and risk of depression and anxiety-related disorders during the first three years after heart transplantation. Psychosomatics. 2001;42:300-313.
119. Woodman CL, Geist LJ, Vance S, et al. Psychiatric disorders and survival after lung transplantation. Psychosomatics. 1999;40:293-297.
120. White HD. Scientific communication and literature retrieval. In: Cooper H, Hedges LV, Valentine JC, eds. Handbook of Research Synthesis and Meta-Analysis. 2nd ed. New York: Russell Sage; 2009:51-72.
121. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York: Wiley; 1981.